“…This is because the amikacin molecule has fewer points susceptible to enzymatic attack than most other aminoglycosides (Chen, Chen, He, Shang, & Zhang, 2012;Nicoli & Santi, 2006;Serrano & Silva, 2006;Yu, He, Fu, Xie, & Gan, 2009), and hence has a broader antibiotic spectrum.…”